The power and the promise of oncogene-induced senescence markers
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Recently, it has been shown that oncogene-induced senescence (OIS) occurs during the early stages of tumorigenesis. Senescent tumour cells are abundant within premalignant neoplastic lesions, whereas they are scarce in malignant tumours. This association of senescence with the premalignant stages of tumour progression opens the possibility of using senescence markers as diagnostic and prognostic tools. Moreover, some chemotherapeutic protocols induce senescence in tumour cells and, consequently, senescence markers could help to monitor treatment response.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Immunohistochemical analysis of the treated tumors showed how Gemcitabine induces a robust senescent response in the tumor as observed from the positive senescence-associated beta-galactosidase (SABG) staining, the loss of proliferation marker Ki67, and the expression of cell cycle inhibitor p21 (Fig. 4d, e), all of them markers of cell senescence41.”
From Identification and characterization of Cardiac Glycosides as senolytic compounds (2019) · cites this paper as [41]
In the citing paper
“As the endogenous expression levels of oncogenes are unlikely to cause OIS, the stochastic accumulation of mutations might be needed for OIS induction [118].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [118]
In the citing paper
“recent data have shown that there are abundant senescent cells within tumours”
From The common biology of cancer and ageing (2007) · cites this paper as [6]
In the citing paper
“the expression of certain oncogenes accelerated the de-repression of the CDKN2a locus, a phenomenon that was called 'oncogene-induced senescence' 5, 6”
From The common biology of cancer and ageing (2007) · cites this paper as [6]
In the citing paper
“Senescent cells acquire a new metabolic state, are protected from apoptosis, and activate a secretory program known as the senescence associated secretory phenotype (SASP)(15–17).”
From Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer (2023) · cites this paper as [17]
Citations
Cites
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 1×
“0, termed senescence-associated β-galactosidase (SA-β-Gal”
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876 · cited 1×
“jpg" NDATA ITEM> ]> Senescence is a cellular stress response The concept of senescence was first applied to the irreversible growth arrest of cells after prolonged proliferation under in vitro , non-physiological condition”
BackgroundOncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“One particularly relevant source of stress is derived from the aberrant proliferative signals of oncogenes, which might eventually trigger senescence through a process known as oncogene-induced senescence (OIS”
BackgroundSelf-citationSenescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 1×
“Only recently, however, has a mechanism with the power to impose such a strict control over proliferation been put forwar”
BackgroundBRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Krtolica, A., Parrinello, S., Lockett, S., Desprez, P.-Y., & Campisi, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211053698 · Cited by 1,730
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Senescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482
Self-citationLowe, S. W., Cepero, E., & Evan, G. (2004) · Nature · doi:10.1038/nature03098 · Cited by 1,309 · cited 1×
“One particularly relevant source of stress is derived from the aberrant proliferative signals of oncogenes, which might eventually trigger senescence through a process known as oncogene-induced senescence (OIS”
BackgroundOncogene-induced senescence as an initial barrier in lymphoma development
Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A. H. F. M., Schlegelberger, B., Stein, H., Dörken, B., Jenuwein, T., & Schmitt, C. A. (2005) · Nature · doi:10.1038/nature03841 · Cited by 1,220
Alcorta, D. A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., & Barrett, J. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13742 · Cited by 1,008
Brunk, U. T., & Terman, A. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00959-0 · Cited by 919
The p16INK4a/CDKN2A tumor suppressor and its relatives
Ruas, M., & Peters, G. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(98)00017-1 · Cited by 911 · cited 1×
“These two pathways are thought to be crucial for tumour suppression and are often mutated in tumour”
BackgroundKurz, D. J., Decary, S., Hong, Y., & Erusalimsky, J. D. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.20.3613 · Cited by 899
Tuveson, D. A., Shaw, A. T., Willis, N. A., Silver, D. P., Jackson, E. L., Chang, S., Mercer, K. L., Grochow, R., Hock, H., Crowley, D., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00085-6 · Cited by 798
Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks
Sedelnikova, O. A., Horikawa, I., Zimonjic, D. B., Popescu, N. C., Bonner, W. M., & Barrett, J. C. (2004) · Nature Cell Biology · doi:10.1038/ncb1095 · Cited by 790 · cited 1×
“The accumulation of unrepaired DNA damage during ageing, as is shown by the presence of γH2AX foci, has been linked to senescence in cell cultures and in ageing organism”
BackgroundMicroarray analysis of replicative senescence
Shelton, D. N., Chang, E., Whittier, P. S., Choi, D., & Funk, W. D. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80420-5 · Cited by 764
Zhang, R., Poustovoitov, M. V., Ye, X., Santos, H. A., Chen, W., Daganzo, S. M., Erzberger, J. P., Serebriiskii, I. G., Canutescu, A. A., Dunbrack, R. L., et al. (2005) · Developmental Cell · doi:10.1016/j.devcel.2004.10.019 · Cited by 699
(2002) · PubMed · Cited by 640
Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context
Guerra, C., Mijimolle, N., Dhawahir, A., Dubus, P., Barradas, M., Serrano, M., Campuzano, V., & Barbacid, M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00191-0 · Cited by 571 · cited 1×
“Oncogenic levels and senescence Most studies of OIS have relied on the overexpression of activated oncogenes, and it might have come as a surprise to find that normal endogenous levels of an activated oncogene do not trigger senescenc”
BackgroundSelf-citationThe INK4A/ARF locus and its two gene products.
Sharpless, N. E., & DePinho, R. A. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80004-5 · Cited by 533 · cited 1×
“These two pathways are thought to be crucial for tumour suppression and are often mutated in tumour”
BackgroundHallmarks of senescence in carcinogenesis and cancer therapy
Shay, J. W., & Roninson, I. B. (2004) · Oncogene · doi:10.1038/sj.onc.1207518 · Cited by 502
Roberson, R. S., Kussick, S. J., Vallieres, E., Chen, S.-Y. J., & Wu, D. Y. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1270 · Cited by 428 · cited 1×
“In the case of human tumours, it is of particular importance that senescence induced by chemotherapy has been shown to be a relevant factor in determining treatment outcome for breast and lung carcinom”
BackgroundPutting the stress on senescence
Serrano, M., & Blasco, M. A. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00278-7 · Cited by 413 · cited 1×
“Now this concept is applied in general to the irreversible proliferate arrest of cells caused by various stresse”
BackgroundSelf-citationReciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines.
Shapiro, G. I., Edwards, C. D., Kobzik, L., Godleski, J. J., Richards, W. G., Sugarbaker, D. J., & Rollins, B. J. (1995) · PubMed · Cited by 377
Is β-Galactosidase Staining a Marker of Senescence in Vitro and in Vivo?
Severino, J., Allen, R. G., Balin, S., Balin, A., & Cristofalo, V. J. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4875 · Cited by 370
Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent
Chang, B.-D., Swift, M. E., Shen, M., Fang, J., Broude, E. V., & Roninson, I. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012602599 · Cited by 312 · cited 1×
“However, it has been known for a long time that chemotherapeutic drugs can also trigger senescence, occasionally named chemotherapy-induced premature senescenc”
BackgroundSenescence, apoptosis and therapy — cutting the lifelines of cancer
Schmitt, C. A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1044 · Cited by 295
Potential Tumor Suppressive Pathway Involving DUSP6/MKP-3 in Pancreatic Cancer
Furukawa, T., Sunamura, M., Motoi, F., Matsuno, S., & Horii, A. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64315-5 · Cited by 216 · cited 1×
“Similarly, some members of the dual-specificity family of phosphatases are induced by Ras and are negative regulators of mitogen activated protein kinase (MAPK) signalling, therefore opposing oncogenic Ras activit”
BackgroundCaspase inhibition switches doxorubicin-induced apoptosis to senescence
Rebbaa, A., Zheng, X., Chou, P. M., & Mirkin, B. L. (2003) · Oncogene · doi:10.1038/sj.onc.1206366 · Cited by 201
Denchi, E. L., Attwooll, C., Pasini, D., & Helin, K. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.7.2660-2672.2005 · Cited by 195 · cited 1×
“Increased expression levels of p16INK4a, ARF and p53 have been found in murine tissues with cells undergoing OIS, as well as in human premalignant neoplastic lesion”
BackgroundThe potential of TRAIL for cancer chemotherapy
Nagane, M., Huang, H.-J. S., & Cavenee, W. K. (2001) · APOPTOSIS · doi:10.1023/a:1011336726649 · Cited by 161
Cellular Response to Oncogenic Ras Involves Induction of the Cdk4 and Cdk6 Inhibitor p15INK4b
Malumbres, M., Pérez De Castro, I., Hernández, M. I., Jiménez, M., Corral, T., & Pellicer, A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2915-2925.2000 · Cited by 153 · cited 1×
“In addition, p15INK4b was previously described as being involved in the growth arrest that is imposed during Ras-induced senescence and was shown to oppose transformation by Ras, at least in cultured cell”
BackgroundAssociation of increased autophagic inclusions labeled for β-galactosidase with fibroblastic aging
Gerland, L.-M., Peyrol, S., Lallemand, C., Branche, R., Magaud, J.-P., & Ffrench, M. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(03)00132-3 · Cited by 130
Molecular signature of oncogenic ras-induced senescence
Mason, D. X., Jackson, T. J., & Lin, A. W. (2004) · Oncogene · doi:10.1038/sj.onc.1208172 · Cited by 127
Masumoto, N., Fujii, T., Ishikawa, M., Saito, M., Iwata, T., Fukuchi, T., Susumu, N., Mukai, M., Kubushiro, K., Tsukazaki, K., et al. (2003) · Human Pathology · doi:10.1016/s0046-8177(03)00284-3 · Cited by 119
Tahara, H., Sato, E., Noda, A., & Ide, T. (1995) · PubMed · Cited by 111
Yamada, K. (2005) · Frontiers in bioscience · doi:10.2741/1772 · Cited by 104 · cited 1×
“DEC1 is a member of the basic helix-loop-helix family of transcription factors and it has been shown to be involved in the control of circadian rhythms, but it also seems to be involved in many different signalling pathway”
BackgroundGiatromanolaki, A., Koukourakis, M. I., Sivridis, E., Turley, H., Wykoff, C. C., Gatter, K. C., & Harris, A. L. (2003) · The Journal of Pathology · doi:10.1002/path.1330 · Cited by 100
Investigation of the role of G1/S cell cycle mediators in cellular senescence
Afshari, C. A., Vojta, P. J., Annab, L. A., Futreal, P. A., Willard, T. B., & Barrett, J. C. (1993) · Experimental Cell Research · doi:10.1006/excr.1993.1306 · Cited by 100
Decoy Receptor 2 (DcR2) Is a p53 Target Gene and Regulates Chemosensitivity
Liu, X., Yue, P., Khuri, F. R., & Sun, S.-Y. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0939 · Cited by 91 · cited 1×
“It suppresses TRAIL-induced apoptosis and has been shown to regulate chemosensitivit”
BackgroundSenescence-initiated Reversal of Drug Resistance
Zheng, X. S., Chou, P. M., Mirkin, B. L., & Rebbaa, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0820 · Cited by 89
Sprouty and cancer: The first terms report
Lo, T. L., Fong, C. W., Yusoff, P., McKie, A. B., Chua, M., Leung, H. Y., & Guy, G. R. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.12.032 · Cited by 89 · cited 1×
“In this sense, the Sprouty family of genes, which are induced by Ras and inhibit Ras signalling, are frequently inactivated during tumour progressio”
BackgroundBarradas, M., Gonos, E. S., Zebedee, Z., Kolettas, E., Petropoulou, C., Delgado, M. D., León, J., Hara, E., & Serrano, M. (2002) · Experimental Cell Research · doi:10.1006/excr.2001.5434 · Cited by 79 · cited 1×
“In a previous effort to identify potential tumour suppressors that are involved in RAS-induced senescence, our group found that the expression of Ras-induced senescence 1 ( RIS1 ) is increased during growth arrest triggered by the overexpression of oncogenic HRAS in human primary cell”
BackgroundSelf-citationYang, N.-C., & Hu, M. (2003) · Analytical Biochemistry · doi:10.1016/j.ab.2003.11.012 · Cited by 61
Mu, X., & Higgins, P. J. (1995) · Journal of Cellular Physiology · doi:10.1002/jcp.1041650324 · Cited by 56 · cited 1×
“Also, plasminogen activator inhibitor 1 ( PAI1 ), an inhibitor of the activity of the urokinase-type plasminogen activator protease, μPA , is upregulated during replicative senescenc”
BackgroundHoornaert, I., Marynen, P., Goris, J., Sciot, R., & Baens, M. (2003) · Oncogene · doi:10.1038/sj.onc.1207089 · Cited by 52
Hama, T., Maruyama, M., Katoh‐Semba, R., Takizawa, M., Iwashima, M., & Nara, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100617200 · Cited by 6
Cited by
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Self-citationModels, mechanisms and clinical evidence for cancer dormancy
Aguirre-Ghiso, J. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2256 · Cited by 1,677
Cellular senescence in cancer and aging.
Collado, M., Blasco, M. A., & Serrano, M. (2007) · Cell · doi:10.1016/j.cell.2007.07.003 · Cited by 1,708
“These findings indicate that senescence restricts tumor progression and might potentially serve as a useful marker for tumor staging (Collado and Serrano, 2006).”
Self-citation
Metadata
- Authors
- Collado, M., & Serrano, M.
- Affiliations
- Spanish National Cancer Research Centre (ES)
- Corresponding author
- Serrano, Manuel
- Venue
- Nature Reviews Cancer
- Published
- 2006-06
- Volume
- 6
- Issue
- 6
- Pages
- 472-476
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1986014209
- Cited by
- 404
- References
- 51
- Citations by year
- 2026: 6 · 2025: 3 · 2024: 7 · 2023: 12 · 2022: 14 · 2021: 20 · 2020: 12 · 2019: 22 · 2018: 21 · 2017: 14 · 2016: 29 · 2015: 21 · 2014: 18 · 2013: 29 · 2012: 28
- FWCI
- 2.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- oncogene-induced senescence, cellular senescence, senescence markers, precancerous lesions, carcinogenesis, tumor progression, cancer diagnosis, cancer prognosis, treatment response monitoring
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Humans, Models, Biological, Neoplasms, Oncogenes, Biomarkers, Tumor, Gene Expression Regulation, Neoplastic, Cellular Senescence, Caspases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.